Literature DB >> 9402871

Protracted arthritis of familial Mediterranean fever (an unusual complication).

F Yalçinkaya1, M Tekin, N Tümer, N Ozkaya.   

Abstract

An unusual case of familial Mediterranean fever and vasculitis in which the patient developed amyloidosis and had protracted arthritis persisting for years is presented. The long-standing arthritis did not respond to corticosteroid and colchicine therapy, but an excellent response to synovectomy was achieved.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9402871     DOI： 10.1093/rheumatology/36.11.1228

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


  6 in total

1.  Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis.

Authors:  Birol Balaban; Evren Yasar; Ahmet Ozgul; Kemal Dincer; Tunc Alp Kalyon
Journal:  Rheumatol Int       Date:  2005-02-12       Impact factor: 2.631

2.  Protracted familial mediterranean fever arthritis presenting as septic arthritis.

Authors:  Hale Usluer; Zelal Bircan
Journal:  Rheumatol Int       Date:  2007-03-27       Impact factor: 2.631

3.  Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation.

Authors:  Rami A Jarjour; Reem Dodaki
Journal:  Mol Biol Rep       Date:  2010-09-16       Impact factor: 2.316

4.  Familial Mediterranean fever mimicking septic arthritis.

Authors:  Imad Uthman; Jinane El-Sayyad; Ihab El-hajj; Abdul-Rahman Bizri
Journal:  Rheumatol Int       Date:  2005-02-08       Impact factor: 2.631

5.  Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever.

Authors:  Mehmet D Demirag; Mehmet A Ozturk; Berna Goker; Seminur Haznedaroglu
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 2.631

6.  Sulphasalazine treatment in protracted familial Mediterranean fever arthritis.

Authors:  Sevcan A Bakkaloglu; Tekin Aksu; Berna Goker; Aysel Unlusoy; Harun Peru; Kibriya Fidan; Oguz Soylemezoglu; Enver Hasanoglu; Necla Buyan
Journal:  Eur J Pediatr       Date:  2008-11-26       Impact factor: 3.183
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.